66 — 9 (47) 2022 — Yusupov A.F., Makhmudov N.Kh., FEATURES OF THE PROGRESSION OF DIABETIC RETINOPATHY UNDER THE INFLUENCE OF CORONAVIRUS INFECTION

FEATURES OF THE PROGRESSION OF DIABETIC RETINOPATHY UNDER THE INFLUENCE OF CORONAVIRUS INFECTION

Yusupov A.F., Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery

Makhmudov N.Kh., Termez branch of the Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery

Resume

This article presents the results of a study of the progression of diabetic retinopathy in patients against the background of coronavirus infection based on the results of a study of retinal microcirculation using angio-OCT methods. The study included 54 patients with diabetic retinopathy who had a coronavirus infection. The analysis was carried out in 2 groups of patients depending on the progression of retinopathy. As the main criterion for progression, the indicator of the area of ​​the foveal avascular zone was studied. It has been established that coronavirus infection can have a significant impact on the progression of diabetic retinopathy, which was confirmed on the basis of angio-OCT data in the form of a significant expansion of the foveal avascular zone, indicating more severe microcirculation disorders and the development of ischemia.

Key words: diabetic retinopathy; coronavirus infection; angio-OCT

First page

395

Last page

400

For citation: Yusupov A.F., Makhmudov N.Kh., FEATURES OF THE PROGRESSION OF DIABETIC RETINOPATHY UNDER THE INFLUENCE OF CORONAVIRUS INFECTION //New Day in Medicine 9 (47)2022 395-400 https://l.clck.bar/c3c41

LIST OF REFERENCES:

1. Abbasi K. The scandals of COVID-19. Editorial. // BMJ. – 2020. – 369. – P. 1434.
2. Ben A.J., Neyeloff J.L., de Souza C.F. et al. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System. // Appl Health Econ Health Policy. – 2020. – 18. – P. 57-68.
3. Landecho M.F., Gandara E. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? // J Intern Med. – 2020.
4. Lian J.X., McGhee S.M., Gangwani R.A., Hedley A.J., Lam C.L., Yap M.K. et al. Screening for diabetic retinopathy with or without a copayment in a randomized controlled trial: influence of the inverse care law. // Ophthalmology. – 2013. – 120. – P. 1247-1253.
5. Li J.O., Lam D.S.C., Chen Y., Ting D.S.W. Novel Coronavirus disease 2019 (COVID-19): The importance of recognizing possible early ocular manifestation and using protective eyewear. // BrJ Ophthalmol. – 2020. – 104(3). – P. 297-298.
6. Marinho P., Marcos A., Romano A., et al. Retinal findings in patients with COVID-19. // Lancet. – 2020. – 395(10237). – P. 1610.
7. Neroev V.V., Okhotsimskaya T.D., Fadeeva V.A. An account of retinal microvascular changes in diabetes acquired by OCT-angiography. // Russian ophthalmological journal. – 2017. – 10(2). – P. 40-45.
8. Rosenbaum L. The Untold Toll – The Pandemic’s Effects on Patients without COVID-19. // N ENgl J Med. – 2020.
9. Wu P., Duan F., Luo C. et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. // JAMA Ophthalmol. – 2020. – 138(5). – P. 575-578.